2 results
Approved WMORecruiting
1. To evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period
Approved WMORecruiting
In this study, the Trachospray device will be evaluated with regard to blocking the airway reflexes during awake videolaryngoscopie.